TNN
Join the fight against monkeypox in the Democratic Republic of Congo as a targeted vaccination campaign for high-risk groups begins. Learn about the efforts to curb the outbreak with support from the EU and US, focusing on vulnerable populations.
Vaccination Campaign Launched in GMA
In a significant effort to combat the spread of monkeypox, a vaccination campaign targeting high-risk groups is underway in GMA, located in the eastern region of the Democratic Republic of Congo (DRC). The Health Ministry in Kesa has announced this initiative as a crucial step to curb the virus, which has tragically resulted in nearly a thousand fatalities this year alone.
Support from the EU and US
Over 200,000 doses of the monkeypox vaccine have been generously donated by the European Union and the United States. This support underscores the international community’s commitment to addressing the outbreak and protecting vulnerable populations.
A Historic Vaccination Ceremony
The campaign was officially launched in the eastern city of Congo, marked by a ceremony attended by senior government officials. This event symbolizes a pivotal moment in the DRC’s ongoing battle against the monkeypox outbreak, which has affected all 26 provinces and spread to over 15 countries across Africa.
Focus on High-Risk Populations
The monkeypox vaccination campaign is uniquely tailored to reach those at heightened risk. Key target groups include:
- Individuals with Pre-existing Conditions: Those who are already weakened or immunocompromised.
- Health Workers: Frontline healthcare providers who are most exposed to the virus.
- Sex Workers: Individuals who may have a higher risk of exposure.
- Cross-Border Traders: Those engaged in trade activities that could increase their chances of encountering the virus.
- Anyone Exposed to Suspected Cases: Individuals who have had contact with confirmed or suspected cases of monkeypox.
Expansion of the Vaccination Efforts
The vaccination exercise began in GMA and is set to expand into North Kivu and South Kivu provinces, areas that have experienced significant impacts from the outbreak. This strategic expansion aims to ensure that the vaccine reaches as many at-risk individuals as possible, ultimately working to contain and reduce the spread of monkeypox in the region.
Conclusion
The ongoing monkeypox vaccination campaign in the DRC highlights a critical public health initiative aimed at protecting vulnerable populations and curbing the outbreak. With substantial support from international donors and a focus on high-risk groups, this effort is essential for safeguarding the health and well-being of communities in the DRC and beyond.